Continuum Advisory’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.5K Buy
+1,485
New +$47.1K ﹤0.01% 834
2025
Q2
Sell
-113
Closed -$2.59K 1335
2025
Q1
$2.59K Sell
113
-54
-32% -$1.3K ﹤0.01% 1260
2024
Q4
$4.23K Buy
167
+28
+20% +$710 ﹤0.01% 1181
2024
Q3
$3.56K Buy
139
+35
+34% +$1.04K ﹤0.01% 1252
2024
Q2
$3.08K Hold
104
﹤0.01% 1195
2024
Q1
$2.79K Buy
+104
New +$2.89K ﹤0.01% 1208

Other funds holding RTO

Continuum Advisory's RTO Position: Q2 2026 in Review

Continuum Advisory opened a new position in Rentokil (RTO) in Q2 2026: 1,485 shares worth $42.5K. The stake represents ﹤0.01% of the portfolio and ranks #834 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in RTO as recently as Q1 2025.

Continuum Advisory first reported a position in RTO in Q1 2024 and has held it in 6 quarters since. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Continuum Advisory held 1,485 shares of Rentokil worth $42.5K as of Q2 2026.
  • Rentokil was a new Continuum Advisory position in Q2 2026.
  • Rentokil made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #834 holding.
  • Continuum Advisory first reported a position in Rentokil in Q1 2024 and has held it in 6 quarters since.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.